Savitz Ryan reported option exercise involving 1,260 shares of Dianthus Therapeutics, Inc. DE at $22.07 for $27.8k on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
EVP, CFO & CBO
EVP, CFO & CBO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$27,808.20Shares × reported price
Shares traded
1,260Common Stock
Price per share
$22.07Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,561Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 12, 2026, 5:32 PM ET2-day reporting delay
Accession
0001992324-26-000010Code M · Transaction 399547
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Sell300$85.16−$25,548Trade 399540
Nov 9, 2026Sell700$86.70−$60,690Trade 399541
Nov 9, 2026Sell1,736$88.84−$154,226.24Trade 399542
Nov 9, 2026Sell37,517$90.12−$3,381,032.04Trade 399543
Nov 9, 2026Sell58,396$90.90−$5,308,196.40Trade 399544
Nov 9, 2026Sell2,064$91.59−$189,041.76Trade 399545
Nov 10, 2026Sell2,561$90.14−$230,848.54Trade 399548
Nov 11, 2026Sell3,044$90.03−$274,051.32Trade 399551
Nov 12, 2026Sell17,724$90.56−$1,605,085.44Trade 399554
Nov 9, 2026Option exercise29,276$0.00$0Trade 399555
Nov 9, 2026Option exercise20,608$0.00$0Trade 399556
Nov 9, 2026Option exercise40,430$0.00$0Trade 399557
Nov 9, 2026Option exercise10,399$0.00$0Trade 399558
Nov 10, 2026Option exercise1,301$0.00$0Trade 399559
Nov 10, 2026Option exercise1,260$0.00$0Trade 399560
Nov 11, 2026Option exercise1,744$0.00$0Trade 399561
Nov 11, 2026Option exercise1,300$0.00$0Trade 399562
Nov 12, 2026Option exercise1,339$0.00$0Trade 399563
Nov 12, 2026Option exercise16,385$0.00$0Trade 399564
Nov 9, 2026Option exercise29,276$17.88$523,454.88Trade 399536
Nov 9, 2026Option exercise20,608$21.77$448,636.16Trade 399537
Nov 9, 2026Option exercise40,430$22.07$892,290.10Trade 399538
Nov 9, 2026Option exercise10,399$8.44$87,767.56Trade 399539
Nov 10, 2026Option exercise1,301$21.77$28,322.77Trade 399546
Nov 11, 2026Option exercise1,744$21.77$37,966.88Trade 399549
Nov 11, 2026Option exercise1,300$22.07$28,691Trade 399550
Nov 12, 2026Option exercise1,339$21.77$29,150.03Trade 399552
Nov 12, 2026Option exercise16,385$22.07$361,616.95Trade 399553
29 transaction rows in this filing. Joint filers share the same rows.

DNTH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DNTH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +0.1%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2026. F2: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.09 to $85.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F3: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.36 to $87.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F4: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.21 to $89.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F5: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.44 to $90.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F6: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.44 to $91.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F7: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.46 to $92.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F8: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F9: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F10: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. F11: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. F12: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. F13: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. F14: The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.